Urinary NGAL and KIM-1 After ESWL

计划入组 50 人 · 首次发布于 2026 年 1 月 14 日

Urinary KIM-1 After Vancomycin or Linezolid Administration

计划入组 5 人 · 首次发布于 2014 年 2 月 20 日

Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

计划入组 120 人 · 首次发布于 2008 年 12 月 9 日

KIM-127

SYX-KIM

1-naphthaleneacetic acid

C₁₂H₁₀O₂

Kim, Edward

United States

HYUNJOONG KIM

Australia

KYUNGMI KIM

Australia

KIM-1 Emerges as Promising Prognostic Biomarker in Advanced Renal Cell Carcinoma

PD-L1 and KIM-1 Expression Predict Outcomes in Adjuvant Nivolumab Treatment for ccRCC

Adjuvant Pembrolizumab Maintains Survival Benefit in Renal Cell Carcinoma